MIAMI, FLORIDA, UNITED STATES, May 31, 2024 / EINPresswire.com / -- Megalabs, a leading pharmaceutical company, has acquired majority interest and control of DS Laboratories (“DS Labs”), a leading ...
DS Labs’ leading portfolio of products will significantly strengthen Megalabs’ position in dermatology, making its offering more competitive and comprehensive. This solidifies Megalabs as one of the ...
DS Labs will benefit from Megalabs' distribution network and operational expertise, accelerating the development and delivery of new treatments globally. "Our mission has always been to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results